HK1041922A1 - An assay to detect a binding partner - Google Patents

An assay to detect a binding partner

Info

Publication number
HK1041922A1
HK1041922A1 HK02103468.5A HK02103468A HK1041922A1 HK 1041922 A1 HK1041922 A1 HK 1041922A1 HK 02103468 A HK02103468 A HK 02103468A HK 1041922 A1 HK1041922 A1 HK 1041922A1
Authority
HK
Hong Kong
Prior art keywords
assay
detect
binding partner
leukemia
sample
Prior art date
Application number
HK02103468.5A
Other languages
English (en)
Inventor
Richard Ian Christopherson
Remedios Cristobal Guillermo Dos
Original Assignee
Medsaic Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP7916A external-priority patent/AUPP791698A0/en
Priority claimed from AUPQ0425A external-priority patent/AUPQ042599A0/en
Application filed by Medsaic Pty Ltd filed Critical Medsaic Pty Ltd
Publication of HK1041922A1 publication Critical patent/HK1041922A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Basic Packing Technique (AREA)
  • Motorcycle And Bicycle Frame (AREA)
HK02103468.5A 1998-12-23 2002-05-07 An assay to detect a binding partner HK1041922A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP7916A AUPP791698A0 (en) 1998-12-23 1998-12-23 An assay
AUPQ0425A AUPQ042599A0 (en) 1999-05-18 1999-05-18 An assay-ii
PCT/AU1999/001156 WO2000039580A1 (fr) 1998-12-23 1999-12-23 Essai pour la detection d'un partenaire de liaison

Publications (1)

Publication Number Publication Date
HK1041922A1 true HK1041922A1 (en) 2002-07-26

Family

ID=25645962

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103468.5A HK1041922A1 (en) 1998-12-23 2002-05-07 An assay to detect a binding partner

Country Status (15)

Country Link
US (1) US7560226B2 (fr)
EP (1) EP1151300B1 (fr)
JP (1) JP4763135B2 (fr)
KR (1) KR100795757B1 (fr)
CN (1) CN1231761C (fr)
AT (1) ATE466280T1 (fr)
BR (1) BR9916449A (fr)
CA (1) CA2356286C (fr)
DE (1) DE69942314D1 (fr)
DK (1) DK1151300T3 (fr)
ES (1) ES2344180T3 (fr)
HK (1) HK1041922A1 (fr)
NZ (1) NZ525421A (fr)
PT (1) PT1151300E (fr)
WO (1) WO2000039580A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2319828A1 (fr) * 1998-01-29 1999-08-05 Miller, Samuel Series haute densite pour l'analyse des proteomes et procedes et compositions pour ces derniers
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
CA2431911A1 (fr) 2000-12-14 2002-06-20 Paul Stroobant Proteomiques saisie par differentiel de phage
EP1248108B1 (fr) 2001-03-29 2011-08-31 Canon Kabushiki Kaisha méthode de criblage cellulaire et substrats adaptés
WO2002084249A2 (fr) 2001-04-10 2002-10-24 The Board Of Trustees Of The Leland Stanford Junior University Utilisation therapeutique et diagnostique de profils de specificite d'anticorps
US20030044389A1 (en) * 2001-07-02 2003-03-06 Brown Patrick O. Microarrays for cell phenotyping and manipulation
US7718387B2 (en) 2001-09-20 2010-05-18 Board Of Regents, The University Of Texas System Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
US20070233391A1 (en) * 2002-03-07 2007-10-04 Cambridge University Technical Service Limited (CUTS) Scd fingerprints
WO2004001377A2 (fr) * 2002-06-20 2003-12-31 Paul Stroobant Procedes ameliores appliques a la proteomique par capture differentielle
DE10236101A1 (de) * 2002-08-05 2004-02-26 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren und Kit zur Durchführung funktioneller Tests an biologischen Zellen
EP1599730A2 (fr) * 2003-03-03 2005-11-30 Kouyama, Yoshihisa Procedes et appareil utilises pour la detection et la quantification de divers types de cellules et utilisation d'un bio-disque optique pour leur mise en oeuvre
US20040235027A1 (en) * 2003-03-31 2004-11-25 Regent Of The University Of California Preparation and application of ligand-biopolymer conjugates
SE0301058D0 (sv) 2003-04-10 2003-04-10 Biacore Ab Method and kit for cell analyte assay
WO2004088318A1 (fr) * 2003-04-04 2004-10-14 Biacore Ab Procede et trousse pour bioanalyse d'analytes cellulaires
US8546082B2 (en) * 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20080138808A1 (en) * 2003-09-11 2008-06-12 Hall Thomas A Methods for identification of sepsis-causing bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20120122103A1 (en) * 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
DE102004039628A1 (de) * 2004-08-10 2006-02-23 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Trägerplatte zur Durchführung funktioneller Tests an biologischen Zellen sowie Verfahren zur Beschichtung der Trägerplatte
EP1888784A2 (fr) * 2005-05-18 2008-02-20 Wyeth a Corporation of the State of Delaware Genes de la leucemie et leurs utilisations
WO2006132666A1 (fr) * 2005-06-06 2006-12-14 Decision Biomarkers, Inc. Epreuves fondees sur des agencements d'ecoulement liquide
US20070042443A1 (en) 2005-08-17 2007-02-22 Quest Diagnostics Investments Incorporated Hematopoietic cell phenotyping using free circulating cellular markers
JP5127718B2 (ja) * 2005-10-29 2013-01-23 バイエル・テクノロジー・サービシズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング 複雑な組成を有する生物学的起源のサンプル中の１種若しくはそれ以上の被検体の測定方法およびその使用
US20070105165A1 (en) * 2005-11-04 2007-05-10 Charles Goolsby Composite profiles of cell antigens and target signal transduction proteins for analysis and clinical management of hematologic cancers
JP5102772B2 (ja) 2005-11-29 2012-12-19 ザ・ユニバーシティ・オブ・シドニー デミボディ：二量体化活性化治療剤
WO2007087370A2 (fr) * 2006-01-25 2007-08-02 Caprion Pharmaceuticals, Inc. Tat-038 et méthodes d'évaluation et de traitement du cancer
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
CN101449162B (zh) 2006-05-18 2013-07-31 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
WO2009108932A2 (fr) * 2008-02-28 2009-09-03 The Johns Hopkins University Sélection de ligands utiles pour le diagnostic et le traitement du cancer
GB0818614D0 (en) * 2008-10-10 2008-11-19 Univ Dublin City Platelet Analysis
EP2347009A4 (fr) * 2008-10-14 2012-05-30 Caris Mpi Inc Cibles géniques et protéiques exprimées par des gènes représentant des profils de biomarqueurs et des jeux de signatures par type de tumeurs
GB2463401B (en) 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
CA2795776A1 (fr) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Biomarqueurs circulants pour une maladie
AU2011316477A1 (en) * 2010-10-11 2013-05-02 Medsaic Pty Ltd Assay for disease detection
ES2578160T3 (es) * 2011-08-12 2016-07-21 Lsi Medience Corporation Procedimiento de diagnóstico de infecciones de sitio quirúrgico
CN103235124A (zh) * 2013-04-22 2013-08-07 复旦大学 一种基于硝酸纤维素膜的便捷癌细胞捕获芯片
JP6715766B2 (ja) * 2013-06-21 2020-07-01 ザ ジョンズ ホプキンス ユニバーシティ ヒト膜蛋白質の機能および相互作用をプロファイリングするためのビリオンディスプレイアレイ
EP3221704A4 (fr) * 2014-11-20 2018-04-11 GE Healthcare UK Limited Détection de biomarqueurs associés à la démence et à la maladie d'alzheimer et stabilisés sur des matériaux de support solides
CN105005484B (zh) * 2015-08-12 2021-04-20 厦门雅基软件有限公司 一种跨平台游戏开发工具的事件分发方法
CN111163770A (zh) * 2017-07-08 2020-05-15 综合医院公司 鉴定用于治疗阿尔茨海默氏病的治疗性药物或试剂的筛选平台

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA822896B (en) * 1981-04-29 1982-12-29 Ciba Geigy New devices and kits for immunological analysis
US4591570A (en) * 1983-02-02 1986-05-27 Centocor, Inc. Matrix of antibody-coated spots for determination of antigens
US4797356A (en) 1985-12-02 1989-01-10 Konishiroku Photo Industries, Co., Ltd Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5217869A (en) 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5059522A (en) * 1988-08-18 1991-10-22 Wayne Lawrence G Intrinsic enzyme dot blot immunoassay or indentification of microorganisms
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5532135A (en) 1990-02-02 1996-07-02 Cancer Research Fund Of Contra Costa Solid-phase competitive assay utilizing a fusion protein
US5726064A (en) * 1990-11-22 1998-03-10 Applied Research Systems Ars Holding Nv Method of assay having calibration within the assay
US5234816A (en) * 1991-07-12 1993-08-10 Becton, Dickinson And Company Method for the classification and monitoring of leukemias
US5597735A (en) * 1992-05-11 1997-01-28 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health And Welfare Glycolipids for serodiagnosis of tuberculosis and leprosy
JPH07508179A (ja) * 1992-08-21 1995-09-14 シェリング・コーポレーション ヒトインターロイキン−１３
ES2051651B1 (es) * 1992-12-10 1995-01-01 Univ Salamanca Procedimiento para la cuantificacion simultanea, en una sola medicion, de los principales tipos de linfocitos humanos y sus subpoblaciones.
ES2157227T3 (es) * 1993-02-09 2001-08-16 Becton Dickinson Co Asignacion automatica del linaje de leucemias agudas mediante citometria de flujo.
WO1995005604A2 (fr) * 1993-08-13 1995-02-23 Molecular Geriatrics Corporation Procedes de diagnostic de la maladie d'alzheimer
US5692220A (en) * 1993-09-02 1997-11-25 Coulter Corporation Decision support system and method for diagnosis consultation in laboratory hematopathology
ZA947825B (en) * 1993-10-06 1995-08-22 Univ Florida Stem cell proliferation factor.
US5861158A (en) * 1993-11-17 1999-01-19 The United States Of America As Represented By The Deptartment Of Health And Human Services Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
JP3533541B2 (ja) * 1995-01-25 2004-05-31 旭メディカル株式会社 細胞選択フィルター
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6265150B1 (en) * 1995-06-07 2001-07-24 Becton Dickinson & Company Phage antibodies
US5968513A (en) 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
WO1998008083A1 (fr) * 1996-08-20 1998-02-26 Motorola Inc. Procede et appareil de detection de structures moleculaires predeterminees dans un echantillon
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
AU2583899A (en) 1998-02-04 1999-08-23 Invitrogen Corporation Microarrays and uses therefor

Also Published As

Publication number Publication date
WO2000039580A1 (fr) 2000-07-06
EP1151300A1 (fr) 2001-11-07
CA2356286C (fr) 2010-12-21
DE69942314D1 (de) 2010-06-10
DK1151300T3 (da) 2010-07-12
EP1151300B1 (fr) 2010-04-28
CN1231761C (zh) 2005-12-14
KR100795757B1 (ko) 2008-01-21
ATE466280T1 (de) 2010-05-15
JP4763135B2 (ja) 2011-08-31
ES2344180T3 (es) 2010-08-19
JP2002533723A (ja) 2002-10-08
US20020019018A1 (en) 2002-02-14
BR9916449A (pt) 2002-01-22
CN1334922A (zh) 2002-02-06
PT1151300E (pt) 2010-06-21
US7560226B2 (en) 2009-07-14
EP1151300A4 (fr) 2002-07-31
CA2356286A1 (fr) 2000-07-06
NZ525421A (en) 2004-10-29
KR20010093221A (ko) 2001-10-27

Similar Documents

Publication Publication Date Title
HK1041922A1 (en) An assay to detect a binding partner
TR200000565T2 (tr) Biyolojik örneklerdeki analiz bileşenlerinin hızlı analizi için yöntem
EP0797777A4 (fr) Dispositif d'execution d'un ou plusieurs immuno-essais concourants
DE69521104D1 (de) Spezifische Bindungstests und Reagenzien dafür
NZ306051A (en) Testing using electrochemiluminescence
TR199902473T2 (xx) Gen s�ralay�c� ve y�ntemler.
CA2215042A1 (fr) Reactifs et moyens d'analyse
ES2001811A6 (es) Un nuevo material y un nuevo dispositivo utiles en ensayos de fijacionen fase solida para determinar la presencia o la cantidad de un analito en una muestra de ensayo
AU9066998A (en) Use of check surfaces for identifying disturbing samples in a detection procedure
AU3059499A (en) Solid-phase method for antigen and antibody determinations in bloodgroup serology, and test kit
NO20083610L (no) Cobalamin-maling
WO1997036994A8 (fr) Capteur et membrane modifiee pour ce capteur
EP0829723A3 (fr) Méthode de détection homogène pour la détermination de sous-populations d'un analyte
DE69732034D1 (de) Assay-verfahren
IT1212845B (it) Saggio immunologico utilizzante un supporto cromogeno.
MY106963A (en) Agglutination assay.
ATE215095T1 (de) Immunologisches testverfahren zur quantifizierung von peg-modifiziertem humanem granulozyten- kolonie-stimulierender-faktor
ATE312203T1 (de) Dynamische bestimmung von analyten durch arrays auf inneren oberflächen
ES2107828T3 (es) Inmunoensayo.
ES2004066A6 (es) Metodo para analisis cualitativo y-o cuantitativo de antigenos,anticuerpos yno microorganismos u otras celulas y su correspondiente equipo
Hercher et al. Rapid identification of micro-organisms

Legal Events

Date Code Title Description
AS Change of ownership

Owner name: MEDSAIC PTY LIMITED

Free format text: FORMER OWNER(S): UNIVERSITY OF SYDNEY

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20131223